Physicians' and patients' perception of biosimilars and factors affecting biosimilar prescribing in selected Asian Countries: a survey study.

Programs focused on cost/coverage support, patient support, and biosimilar awareness could improve acceptance of biosimilars for chronic immune-mediated inflammatory diseases in Asian countries, thereby increasing patient access to essential biologic therapies.